Compare ARK Genomic Revolution ETF (ARKG) vs Transocean Ltd (RIG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Transocean Ltd — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Transocean Ltd trades at $5.26 (market cap $5.76B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Transocean Ltd nearer its low. Which is the better fit depends on your goals.
| ARKG | RIG | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $7.58 |
52-Week Low | $23.09 | $2.55 |
Market Cap | — | $5.76B |
Enterprise Value | — | $10.70B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Transocean Ltd. (RIG) trades at $5.20, up 1.17% today, with a bearish technical signal and mixed earnings history. The company reported a net loss of -$2.92 billion for 2025 but maintains strong revenue of $3.97 billion and a gross margin of 84.88%. Recent news highlights a $1 billion contract with Equinor and a pending merger with Valaris, aimed at reducing leverage and unlocking synergies.
The outlook is cautiously optimistic, with analyst consensus pointing to a $7.00 price target and 39% buy ratings. Key opportunities include backlog growth and merger benefits, while risks involve persistent net losses, oil price volatility, and execution challenges. The stock's valuation appears attractive with a P/B of 0.7, but profitability remains a concern.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →
